Group ID|Group Name|Treatment Sequence|Treatment Age|Treatment Type|Treatment Quantity|Treatment Unit|Treatment Application|Treatment Remarks|No of individuals in study|Species|Strain|Sex|Age|Group Endpoints|Individual ID|Group ID|Age at death|Pathology type|Pathology location|Pathology Description|
1011-3-1|n/a,n/a|1|100|none (controls)|0|grays|External exposure|n/a|747 (0 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study with diagnosis of myeloid leukaemia from histopathology and haematology|No information on individuals available for this study
1011-3-2|n/a,n/a|1|100|X-rays whole body|1.06|grays|External exposure|10 d continuosly 23.5h/d starting 0.24 Gy/d reduce by 45% every 2 d|734 (0 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study with diagnosis of myeloid leukaemia from histopathology and haematology|No information on individuals available for this study
1011-3-3|n/a,n/a|1|100|X-rays whole body|1.98|grays|External exposure|10 d continuosly 23.5h/d starting 0.48 Gy/d reduce by 45% every 2 d|739 (0 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study with diagnosis of myeloid leukaemia from histopathology and haematology|No information on individuals available for this study
1011-3-4|n/a,n/a|1|100|X-rays whole body|2.6|grays|External exposure|10 d continuosly 23.5h/d starting 0.72 Gy/d reduce by 45% every 2 d|746 (0 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study with diagnosis of myeloid leukaemia from histopathology and haematology|No information on individuals available for this study
1011-3-5|n/a,n/a|1|100|neutrons <100 keV|0.85|grays|Injection, intraperitoneal|90 mBq|732 (0 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study with diagnosis of myeloid leukaemia from histopathology and haematology|No information on individuals available for this study
1011-3-6|n/a,n/a|1|100|neutrons <100 keV|1.86|grays|Injection, intraperitoneal|180 MBq|754 (0 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study with diagnosis of myeloid leukaemia from histopathology and haematology|No information on individuals available for this study
1011-3-7|n/a,n/a|1|100|neutrons <100 keV|3.05|grays|Injection, intraperitoneal|270 MBq|754 (0 in ERA)|Mouse|Mouse, CBA/H|Male|Young Adult|Lifespan study with diagnosis of myeloid leukaemia from histopathology and haematology|No information on individuals available for this study
